MDPI

Cancers Template

Write in a clean editor, then format for Cancers in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Cancers format

Cancers is a peer-reviewed journal published by MDPI, covering Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis. Over its lifetime it has published 37,000 papers, which have received 806,629 citations.

PublisherMDPI
Reference styleNumbered (MDPI)
Numbered — [1], [2] in the text
1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Cancers 2023, 12, 45–58.

Formats any DOI in Cancers style. No sign-up.

Publishes research inCancer Immunotherapy and Biomarkers Cancer Genomics and Diagnostics Cancer Cells and Metastasis Pancreatic and Hepatic Oncology Research Glioma Diagnosis and Treatment
ISSN2072-6694
Citation impact (2-yr)4.75
h-index222
i10-index20,356
Article processing charge$2,598
Open accessYes
Top institutions publishing hereInserm
Journal websitewww.mdpi.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Cancers per year

126
2014
139
2015
112
2016
177
2017
557
2018
2.1K
2019
3.9K
2020
6.5K
2021
6.4K
2022
5.8K
2023
4.2K
2024
4.1K
2025

Citation impact of Cancers by publication year

13.2K
2014
8.2K
2015
7.8K
2016
15.8K
2017
32.8K
2018
104.2K
2019
144.9K
2020
182.2K
2021
127.4K
2022
83.8K
2023
33.5K
2024
12.8K
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Cancers

Drug Resistance in Cancer: An Overview

Genevieve Housman, Shannon Byler, Sarah Heerboth et al. · 5 Sep 2014

Cancers have the ability to develop resistance to traditional therapies, and the increasing prevalence of these drug resistant cancers necessitates further research and treatment development. This paper outlines the current knowledge of mechanisms that promote or enable drug resistance, such as drug inactivation, drug target alteration, drug efflux, DNA damage repair, cell death inhibition, and…

2,457 citations Cite SaveGo to paper →
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways

Ping Wee, Zhixiang Wang · 17 May 2017

The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that is commonly upregulated in cancers such as in non-small-cell lung cancer, metastatic colorectal cancer, glioblastoma, head and neck cancer, pancreatic cancer, and breast cancer. Various mechanisms mediate the upregulation of EGFR activity, including common mutations and truncations to its extracellular domain, such as…

1,992 citations Cite SaveGo to paper →
Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review

Sergiusz Łukasiewicz, Marcin Czeczelewski, Alicja Forma et al. · 25 Aug 2021

Breast cancer (BC) is the most frequently diagnosed cancer in women worldwide with more than 2 million new cases in 2020. Its incidence and death rates have increased over the last three decades due to the change in risk factor profiles, better cancer registration, and cancer detection. The number of risk factors of BC is…

1,889 citations Cite SaveGo to paper →
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects

Ana-Maria Florea, Dietrich Büsselberg · 15 Mar 2011

Platinum complexes are clinically used as adjuvant therapy of cancers aiming to induce tumor cell death. Depending on cell type and concentration, cisplatin induces cytotoxicity, e.g., by interference with transcription and/or DNA replication mechanisms. Additionally, cisplatin damages tumors via induction of apoptosis, mediated by the activation of various signal transduction pathways, including calcium signaling, death…

1,766 citations Cite SaveGo to paper →
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment

Theerawut Chanmee, Pawared Ontong, Kenjiro Konno et al. · 13 Aug 2014

During tumor progression, circulating monocytes and macrophages are actively recruited into tumors where they alter the tumor microenvironment to accelerate tumor progression. Macrophages shift their functional phenotypes in response to various microenvironmental signals generated from tumor and stromal cells. Based on their function, macrophages are divided broadly into two categories: classical M1 and alternative M2…

1,583 citations Cite SaveGo to paper →

Cancers template — frequently asked questions

How do I write a paper in the Cancers format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Cancers template. When you export, DocuGuru compiles the paper into the official MDPI format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Cancers use?
Cancers uses Numbered (MDPI) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Cancers 2023, 12, 45–58.
Do I need to know LaTeX to submit to Cancers?
No. DocuGuru generates the mdpi LaTeX class and compiles the PDF for you in the background, so you get a MDPI-ready Cancers document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Cancers template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Cancers format with correct headings, figures, tables, and numbered citations.
What is Cancers?
Cancers - MDPI Journal. It is a multidisciplinary journal, published by MDPI.
Can I export a submission-ready Cancers PDF?
Yes — DocuGuru produces a PDF built with the official Cancers template (the mdpi class) that is ready to submit to MDPI, together with the matching LaTeX source files.
How much does the Cancers template cost?
You can start writing in the Cancers template for free. Exporting the final submission-ready Cancers PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Cancers template